Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://safanpei054694.blogcudinti.com/36413138/tirzepatide-a-promising-new-treatment-for-obesity